News

Catch up on coverage from the first day of the 2025 SDPA Annual Summer Dermatology Conference held in Washington, DC.

A poster at SDPA 2025 highlights the importance of early biopsy and genetic testing in aggressive cSCC, even in young patients without classic risk factors.

Almirall showcased groundbreaking research on atopic dermatitis, psoriasis, and actinic keratosis at the 2025 ICD.

DFD-29 showed strong efficacy in rosacea regardless of body weight in 2 phase 3 trials, outperforming both placebo and doxycycline.

Galderma launches clinical trials for nemolizumab, targeting systemic sclerosis and chronic pruritus of unknown origin, addressing critical patient needs.

Eileen Cheever, MPAS, PA-C, previews the SDPA Summer Dermatology Conference, calling it a can't-miss opportunity to learn, network, and reconnect.

Abeona Therapeutics' VIITAL trial reveals promising results for RDEB treatment, showcasing significant wound healing and pain relief with Zevaskyn therapy.

Click here to answer our poll and let us know what you're looking forward to at the SDPA's summer conference.

Arcutis Biotherapeutics' roflumilast cream 0.15% gains strong AAD endorsement for effective AD management in adults and children.

Join Dermatology Times at SDPA 2025 as our expert board members take the stage to share clinical insights, pearls, and practice-changing perspectives.

The conference aimed at providing dermatology physician assistants with the latest in the specialty begins today in Washington, DC.

Sonia Batra, MD, shares effective summer acne solutions using lasers such as Aerolase Neo Elite and AviClear, ensuring tailored care for optimal skin health.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Explore insights on benzoyl peroxide and benzene risks in acne treatment from experts Renata Block, DMSc, MMS, PA-C, and John Barbieri, MD, MBA.

Discover the latest advancements in vitiligo treatment and awareness as Dermatology Times highlights this year's progress during Vitiligo Awareness Month.

Sonia Batra, MD, dispels common myths and shares expert tips on summer skin care for acne, emphasizing sun protection and tailored regimens.

Dermatology Times is recapping our exclusive expert interviews from the month of June.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Explore innovative strategies for managing chronic hand eczema, focusing on personalized care, early treatment, and understanding complex subtypes for better outcomes.

Remission is now defined as 0% BSA or IGA 0 for ≥6 months on treatment, per a Delphi consensus led by the National Psoriasis Foundation.

Renata Block, DMSc, MMS, PA-C, speaks with Adam Friedman, MD, FAAD, on innovative teledermatology initiatives in Washington, DC, addressing health care disparities and enhancing community access.

Discover Hershel Dobkin's unique blend of humor and dermatology, offering insights that combat clinical burnout and bring joy to medical practice.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

PP405 shows promise for hair regrowth in phase 2a trial, with 31% seeing >20% density increase; phase 3 studies are planned for 2026.

Iris Rubin, MD, highlights SEEN's science-backed hair care, designed for acne-prone skin, improving scalp health and reducing irritation.

UC Berkeley’s Broc Vargo shares how growing up in tanning salons inspired his passion for dermatology, sun safety, and public health advocacy.

Iris Rubin, MD, reveals how her brand SEEN transforms hair products to combat acne, promoting clearer skin through innovative, skin-friendly formulations.

Explore the top headlines of the week including insights on the latest clinical trials, therapeutic updates, and more.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

In case you missed it, this week we had news about the FDA approval of dupilumab for bullous pemphigoid, the upcoming INTEGUMENT-INFANT trial for roflumilast, nail trends that challenge clinical diagnosis, and more.